-
Catalent Divests Blow-Fill-Seal Sterile CDMO Business
contractpharma
January 08, 2021
SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has acquired the Blow-Fill-Seal (BFS) sterile contract development and manufacturing business from Catalent Pharma Solutions.
-
Bioclinica Acquires Saliency
contractpharma
January 07, 2021
Bioclinica, an integrated solutions provider of clinical life science and technology expertise, has acquired Silicon Valley-based Saliency.
-
Aceto to Acquire IsleChem
contractpharma
January 05, 2021
Aceto, a global virtual manufacturer of specialty materials for life sciences has acquired NY-based, IsleChem, a provider of chemical manufacturing, contract research and development (R&D), analytical services, and technical and support services.
-
Charles River Labs Acquires Distributed Bio
contractpharma
January 05, 2021
Charles River Laboratories has acquired Distributed Bio, Inc. for $83 million in cash, subject to customary closing adjustments.
-
Centene Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx)
prnewswire
December 31, 2020
Centene Corporation announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases.
-
Advanced Enzyme Technologies to acquire SciTech Specialties for Rs 316.26 million
expresspharma
December 28, 2020
On completion of the aforesaid investment, Advanced Enzyme Technologies will get a controlling stake of 51 per cent in SciTech Specialties with a total shareholding of 520,408 equity shares.
-
Model N to acquire Deloitte’s Life Sciences pricing and contracting solutions business
expresspharma
December 21, 2020
Model N announced that it has entered into a definitive agreement to acquire Deloitte’s life sciences pricing and contracting solutions business and underlying technology.
-
Novartis to acquire Cadent Therapeutics for $770 mn
expresspharma
December 18, 2020
Novartis gains full rights to Cadent’s NMDAr allosteric modulator program, pre-clinical programs and clinical stage movement disorder program.
-
AstraZeneca to acquire Alexion
expresspharma
December 14, 2020
AstraZeneca and Alexion Pharmaceuticals have entered into a definitive agreement for AstraZeneca to acquire Alexion.
-
LINK Medical Acquires IRW Consulting AB
contractpharma
December 10, 2020
LINK Medical has acquired IRW Consulting AB (IRW), a Nordic CRO with more than 20 years of experience in clinical research outsourcing.